Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

B and T Lymphocyte Associated (BTLA) (Center) Peptid

BTLA Reaktivität: Human Wirt: Synthetic BP, BI Sodium azide
Produktnummer ABIN5686037
  • Target Alle BTLA Produkte
    BTLA (B and T Lymphocyte Associated (BTLA))
    Protein Region
    Center
    Spezies
    Human
    Quelle
    • 4
    Synthetic
    Applikation
    Blocking Peptide (BP), BioImaging (BI)
    Produktmerkmale
    17 amino acids near the center of human BTLA.
  • Applikationshinweise
    The peptide is used for blocking the activity of BTLA antibody . It usually blocks the antibody activity completely by incubating the peptide with equal volume of antibody for 30 min at 37˚,C.
    Beschränkungen
    Nur für Forschungszwecke einsetzbar
  • Format
    Liquid
    Rekonstitution
    PBS  pH 7.2 (10 mM NaH2PO4, 10 mM Na2HPO4, 130 mM NaCl) containing 0.1 % bovine serum albumin and 0.02 % sodium azide
    Konzentration
    200 μg/mL
    Konservierungsmittel
    Sodium azide
    Vorsichtsmaßnahmen
    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    Lagerung
    -20 °C
    Informationen zur Lagerung
    Store BTLA peptide at -20°C, stable for one year.
    Haltbarkeit
    12 months
  • Target
    BTLA (B and T Lymphocyte Associated (BTLA))
    Synonyme
    BTLA Peptide, BTLA1 Peptide, CD272 Peptide, A630002H24 Peptide, B and T lymphocyte associated Peptide, BTLA Peptide, Btla Peptide
    Gen-ID
    151888
    NCBI Accession
    NP_861445
    OMIM
    145580621
    UniProt
    Q7Z6A9
Sie sind hier:
Kundenservice